Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025 - Europe’s premier industry-focused forum dedicated ...

The main opportunities in the Global Nanoparticle Contract Manufacturing Services Market include increasing reliance on CDMOs ...

The global lipid nanoparticle manufacturing market size was valued at USD 475 million in 2025 and is predicted to hit around ...

MAINZ, GERMANY, December 21, 2022 — BioNTech SE (BNTX) (Nasdaq: BNTX, “BioNTech”) reached the next milestone in the establishment of scalable mRNA vaccine production in Africa. The six ISO-sized ...

Opportunities in the mRNA quality monitoring market include the rising demand for QC due to the expansion of mRNA ...

CAMBRIDGE, MA / ACCESS Newswire / November 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced the expansion of its U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing ...

Newly accredited GMP facility for commercial manufacturing of mRNA in anticipation of customer BLA submission. Kaneka Eurogentec, an FDA, EMA inspected CDMO focused on the production of injectable ...

The "mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA ...

Moderna (NASDAQ:MRNA) has cancelled plans to build a messenger RNA manufacturing plant in Japan, citing concerns over the current business environment, the Japanese business publication Nikkei Asia ...

New capabilities strengthen U.S. production, completing Moderna’s domestic end-to-end mRNA manufacturing network More than $140 million investment will create hundreds of highly skilled ...